Tunel Assay

Terminal deoxynucleotidyl transferase identifies exposed 3′-hydroxyl ends created when DNA strands break and adds labeled nucleotides to those sites. This enzymatic labeling converts otherwise difficult-to-observe DNA damage into a detectable signal. The resulting signal allows investigators to locate affected individual cells or quantify labeled populations, depending on the selected readout.

DNA fragmentation indicates that strand breaks are present, but the signal alone does not uniquely identify why the cell died or was damaged. Consequently, TUNEL results should be interpreted with other cellular markers when distinguishing biological processes. This combined approach is especially important in disease models, toxicology studies, and experiments evaluating treatment responses.

Microscopy reveals where labeled cells occur within tissue sections or cultured-cell preparations, preserving information about cellular and tissue location. Flow cytometry instead measures labeling across a cell population, supporting population-level assessment. Choosing between them depends on whether the study emphasizes spatial distribution in a specimen or quantitative comparison among individual cells within analyzed samples.

The assay can be applied to tissue sections, cultured cells, and disease models. Tissue sections support examination of cell death within anatomical context, whereas cultured cells allow analysis in controlled experimental systems. Disease models extend the approach to biologically relevant damage or pathology. In each setting, the labeled signal identifies cells containing fragmented DNA.

TUNEL labeling supports studies of apoptosis in development, neurodegeneration, cancer, and toxicology. It can reveal where fragmented DNA occurs in tissues or cell preparations and help assess how cell death changes across an experimental condition. Because the method detects a cellular outcome rather than a unique cause, interpretation is strongest when paired with complementary markers.

In disease models, the assay can indicate the extent and distribution of DNA fragmentation associated with tissue damage or cell death. In treatment-response studies, researchers can compare labeled cells between experimental conditions to assess changes in this outcome. Such comparisons require careful interpretation because increased or decreased labeling alone does not establish the underlying death mechanism.